Table 2.
Composite score summary of visual function questionnaire (NEI VFQ-25) and (NEI VFQ-25 (Neuro 10))
NEI VFQ-25 | NEI VFQ-25 (10) | |||||||
---|---|---|---|---|---|---|---|---|
Treatment | Treatment | |||||||
Fresnel prisms | Visual search training | Standard care | Total | Fresnel prisms | Visual search training | Standard care | Total | |
Patients randomised | 26 | 30 | 29 | 85 | 26 | 30 | 29 | 85 |
Baseline data | 25 | 30 | 28 | 83 | 25 | 30 | 28 | 83 |
26 weeks data | 24 | 25 | 19 | 68 | 24 | 25 | 19 | 68 |
Data at both time points | 23 | 25 | 19 | 67 | 23 | 25 | 19 | 67 |
Baseline mean (sd) (min, max) |
59.5 (15.5) (16.0, 84.6) |
51.7 (18.8) (24.6, 82.2) |
52.4 (18.3) (24.4, 81.2) |
54.6 (17.7) (16.0, 84.6) |
68.5 (16.2) (19.8, 93.9) |
59.5 (19.0) (32.2, 92.9) |
61.8 (19.2) (35.0, 91.0) |
63.2 (18.3) (19.8, 93.9) |
26 week follow-up assessment mean (sd) (min, max) |
58.6 (17.9) (16.0, 88.1) |
58.9 (19.2) (18.8, 88.0) |
50.3 (21.9) (13.6, 83.2) |
56.3 (19.6) (13.6, 88.1) |
68.1 (18.8) (18.2, 96.5) |
68.4 (20.0) (25.5, 99.2) |
59.8 (22.7) (22.9, 95.2) |
65.9 (20.5) (18.2, 99.2) |
Difference at 26 weeks from baseline mean (sd) 95% CI |
−0.9 (13.1) −6.6 to 4.7 |
7.2 (15.5) 0.8 to 13.6 |
−2.1 (11.1) −7.4 to 3.3 |
1.8 (14.0) −1.6 to 5.2 |
−0.4 (13.7) −6.3 to 5.5 |
8.9 (16.8) 2.0 to 15.8 |
−1.9 (12.7) −8.1 to 4.1 |
2.6 (15.2) −1.1 to 6.4 |